Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement

Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement

Abstract Background Patient registry data serves an increasing role in drug safety and comparative effectiveness research, but registry databases often do not contain confounder information measured at the same time that treatments begin. This study evaluated a set of approaches for estimating confo...

Full description

Bibliographic Details
Main Authors: Daniel H. Solomon, Nancy A. Shadick, Michael E. Weinblatt, Agnes Zak, Michelle Frits, Jessica M. Franklin
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Comparative effectiveness research
Disease-modifying antirheumatic drugs
TNF antagonist
Infection
Online Access:http://link.springer.com/article/10.1186/s13075-017-1330-0

Internet

http://link.springer.com/article/10.1186/s13075-017-1330-0

Similar Items